The PFNT Facility is a coherent set of exploration tools in neurobiology allowing research at the molecular, cellular and integrated levels.
Nicola Allen - Associate Professor at the Molecular Neurobiology Laboratory of the Salk Institute for Biological Studies in La Jolla, USA - est l'invitée de Neuroschool ce mois-ci pour un séminaire sur son domaine de recherche: "Astrocyte regulation of neuronal synapses". Dr Allen viendra donner son séminaire le 13 mai 2022 à 14h30 à l'amphithéâtre du CERIMED, sur le campus de la Timone (vue aérienne).
Le séminaire est ouvert à toute la communauté, et est organisé dans le cadre des séminaires tuteurés de NeuroSchool, à l'initiative des étudiants PhD.
Chiara Bastiancich, Post-doc in the GlioME team presented her ongoing GlioRET project at the European Symposium on Controlled Drug Delivery.
Her poster "Elucidating the tumor resection microenvironment of glioblastoma toward the development of fit-for-purpose local treatments" won over the cogress jury !
Emmanuel Snacel-Fazy, a 2nd year doctoral student in the GlioME team, won the best poster award at yesterday's "Conference Annuelle de L'institut Cancer et Immunologie (ICI)", Thursday 31 March 2022.
His work on the "Remodelling of the glioblastoma immune landscape by smac mimetic GDC-0152" has been appreciated and rewarded. Once again, congratulations!
Dr Romain Appay, pathologist at the Timone Hospital and PhD student in the GioME team, has published a new research paper entitled "Rosette-forming glioneuronal tumours are midline, FGFR1- mutated tumours" in the Neuropathology and Applied Neurobiology journal.
The latest article for NPD team 1 has been published this month into the Journal of Neuroinflammation.
Membrane-type matrix metalloproteinase 5 (MT5-MMP) deficiency in the 5xFAD mouse model of Alzheimer's disease reduces brain neuroinflammation along with amyloidosis, and prevents deficits in synaptic activity and cognition in prodromal stages of the disease. In addition, MT5-MMP deficiency prevents interleukin-1 beta (IL-1β)-mediated inflammation in the peripheral nervous system.
Don't miss the next Neuro'binar of NeuroMarseille with Emmanuel Nivet (Team 6) !
Next Tuesday, on March 22nd, 2022, at 1 pm online, discover Dr Emmanuel Nivet's work in the 13th edition of Neuro'binar:
🔘 Emmanuel Nivet (INP) will present his research topic entitled: "Human induced pluripotent stem cells to study the role of astrocytes in Alzheimer’s disease"
🔘 Hannah Ihme (INT) and Martha Montse Rangel-Sosa (IBDM) - Ph.D. students - will present each other's Ph.D. projects in 5 min.
If you want to know more about the treatment of glioblastoma with Gold Nanorods, click on the title "Well-Defined Polyethylene Glycol Microscale Hydrogel Blocks Containing Gold Nanorods for Dual Photothermal and Chemotherapeutic Therapy" , a publication co-authored by Chiara Bastiancich, post-doc in the GlioME team.
Après une période transitoire où il est resté sur le site de la faculté Nord, le spectromètre de masse de l'INP (Thermo Scientific Q-exactive) est arrivé sur le site Timone cet été. Maya Belghazi ayant quitté l'INP pour rejoindre l'IMM, Claude Villard est dorénavant votre seul interlocuteur pour les projets en lien avec cet appareil.
After being postponed in 2021, the inauguration of the Nikon Center of Excellence for Neuro-Nanoimaging at Aix-Marseille Université (see more details on the Center of Excellence below) will take place on September 22, 2022 starting at 9:00 am on the Timone campus (Grisoli amphitheater), in the presence of the President of AMU Mr. Eric Berton and the Director of Nikon Europe Mr. Takaharu Sasaoka.
Team 6 was happy to participate in NeuroMarseille's day, which took place on June 28, 2022.
Many members of the INP attended this scientific and friendly day for the neuroscience community.
Our M1 student, Marine Dos Santos, also presented her one-month work in our team, during the afternoon poster session.
We thank NeuroMarseille for this great day !
On the 20-22 nd June, the first Molecular Scale Biophysics Research Infrastructure (MOSBRI) conference was held in Paris. Dahbia Yatoui from team 9 and Géraldine Ferracci from PINT went to this event, where Dahbia had the opportunity to present her work "Role of zinc-binding sites in Tau aggregation" on a poster.
The GlioME team was represented on 8 and 9 June 2022 at the Sunrise (Solid tumor cancer stem cell network) meeting at the Curie Institute in Paris.
Aurélie Soubéran presented a poster on the role of the ML-IAP protein in glioblastoma growth and Aurélie Tchoghandjian presented the team's work on "Smac mimetic as pan-cellular therapy in glioblastoma".